Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study
Emerging Classic

Patient perspectives on the use of artificial intelligence for skin cancer screening: a qualitative study.

Nelson CA, Pérez-Chada LM, Creadore A, et al. Patient perspectives on the use of artificial intelligence for skin cancer screening: a qualitative study. JAMA Dermatol. 2020;156(5):501-512. doi:10.1001/jamadermatol.2019.5014.

Save
Print
April 1, 2020
Nelson CA, Pérez-Chada LM, Creadore A, et al. JAMA Dermatol. 2020;156(5):501-512.
View more articles from the same authors.
Researchers in this study used semi-structured interviews to explore how patients perceive the use of direct-to-patient and clinician decision-support artificial intelligence (AI) tools for skin cancer screening. Common perceived benefits included increased diagnostic speed and health care access, while increased anxiety was a common risk. Patients perceived more accurate diagnoses (69%) and less accurate diagnoses (85%) to be both the greatest strength and weakness of these tools. The vast majority of patients (94%) expressed the importance of a symbiotic relationship between patients, physicians and AI tools. The related commentary discusses the importance of including the patient perspective in the development and implementation of AI tools in healthcare.
Save
Print
Cite
Citation

Nelson CA, Pérez-Chada LM, Creadore A, et al. Patient perspectives on the use of artificial intelligence for skin cancer screening: a qualitative study. JAMA Dermatol. 2020;156(5):501-512. doi:10.1001/jamadermatol.2019.5014.